MedTech News
.................... by Andrew Celentano
20,000 lab-grown human retinas reveal how cone photoreceptor cells resist degeneration
Scientists led by Botond Roska at the Institute of Molecular and Clinical Ophthalmology Basel (IOB) and collaborators have identified genetic pathways and compounds capable of protecting cone photoreceptors from the degeneration that underlies conditions like age-related macular degeneration.
Organ-on-a-chip technology replicates decades of human aging in just four days
Over one billion people worldwide are over 60, and the population is projected to more than double by 2050. But as more people live into their 60s, 70s, and 80s, health care systems across the globe may face new challenges as they attempt to manage associated increases in age-related disease.
Placing battery tech directly on tissue to deliver lithium ions for targeted pain relief
A new study from the University of Chicago taps an ingredient most often used in the lithium-ion batteries that power our devices to open new avenues in biomedical technology. Lithium plays vital roles in the body, but taking it orally can have unwanted side effects—so a pair of UChicago chemistry labs teamed up to find a way to deliver lithium only to the exact places where it’s needed.
Butterfly Network strikes US first with POCUS gestational age tool clearance
Butterfly’s GA tool within its point-of-care ultrasound (POCUS) system is intended for rollout in regions with socioeconomic barriers to obstetric imaging services.
FDA approves Anumana’s pulmonary hypertension algorithm
The algorithm integrates with EHR systems and ECG platforms, operating within the health system without external data transfer.
Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System
BOSTON, March 30, 2026 /PRNewswire/ — Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced U.S. Food and Drug Administration (FDA) approval to expand the labeling for the VASCADE MVP® XL venous vascular closure system to include procedures using 10-14F inner diameter (ID) and up to 17F outer diameter (OD) procedural sheaths. With this label expansion, the VASCADE MVP XL system is approved for larger sheaths used in market-leading technologies for pulsed field ablation (PFA) and left atrial appendage closure (LAAC) to treat atrial fibrillation.
Boston Scientific receives FDA clearance for the Asurys™ Fluid Management System
New technology designed to provide a single irrigation management system for ureteroscopy, cystoscopy, percutaneous nephrolithotomy (PCNL) and benign prostatic hyperplasia (BPH) procedures
4DMedical receives CE Mark for CT:VQ™, enabling commercial launch across the European Union
4DMedical Limited (ASX:4DX), the global leader in cardiothoracic imaging software, announces that its latest imaging technology, CT:VQ™ has received CE Mark certification for commercial use in the European Union.